Zuan Lin

490 total citations
18 papers, 325 citations indexed

About

Zuan Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Zuan Lin has authored 18 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Zuan Lin's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Zuan Lin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Zuan Lin collaborates with scholars based in China, Japan and Italy. Zuan Lin's co-authors include Shaodong Hong, Yixin Zhou, Xuanye Zhang, Hongyun Zhao, Li Zhang, Chen Chen, Yan Huang, Yunpeng Yang, Wenfeng Fang and Wenqi Jiang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Zuan Lin

18 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuan Lin China 9 216 107 103 86 41 18 325
Malin Sternby Eilard Sweden 10 129 0.6× 108 1.0× 81 0.8× 45 0.5× 75 1.8× 27 314
Vincent E. Gaillard Switzerland 10 170 0.8× 229 2.1× 74 0.7× 75 0.9× 47 1.1× 21 348
Yugo Kai Japan 11 126 0.6× 81 0.8× 112 1.1× 44 0.5× 54 1.3× 47 297
Maridi Aerts Belgium 8 75 0.3× 143 1.3× 60 0.6× 88 1.0× 89 2.2× 26 256
Yan‐Jun Xiang China 11 88 0.4× 232 2.2× 78 0.8× 69 0.8× 51 1.2× 32 302
Lorraine Blaise France 9 81 0.4× 150 1.4× 99 1.0× 34 0.4× 42 1.0× 28 232
Yizhen Fu China 13 112 0.5× 227 2.1× 84 0.8× 78 0.9× 100 2.4× 38 384
Guosheng Yuan China 11 77 0.4× 255 2.4× 146 1.4× 71 0.8× 48 1.2× 40 344
Morven Cunningham United Kingdom 10 74 0.3× 222 2.1× 184 1.8× 62 0.7× 55 1.3× 21 373
Ann Tan United States 7 98 0.5× 70 0.7× 53 0.5× 61 0.7× 95 2.3× 16 235

Countries citing papers authored by Zuan Lin

Since Specialization
Citations

This map shows the geographic impact of Zuan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuan Lin more than expected).

Fields of papers citing papers by Zuan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuan Lin. The network helps show where Zuan Lin may publish in the future.

Co-authorship network of co-authors of Zuan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zuan Lin. A scholar is included among the top collaborators of Zuan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuan Lin. Zuan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Zhang, Xuanye, Yixin Zhou, Hualin Chen, et al.. (2022). PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma. Frontiers in Immunology. 13. 1015444–1015444. 7 indexed citations
3.
Chen, Chen, Lina He, Yixing Wang, et al.. (2022). Optimizing the tumor shrinkage threshold for evaluating immunotherapy efficacy for advanced non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 149(3). 1103–1113. 1 indexed citations
4.
5.
Wang, Yixing, Sha Fu, Tao Chen, et al.. (2022). A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment. Thoracic Cancer. 13(11). 1558–1569. 8 indexed citations
6.
7.
Chen, Chen, Yixin Zhou, Xuanye Zhang, et al.. (2021). Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer. Frontiers in Immunology. 12. 736943–736943. 1 indexed citations
8.
Lin, Zuan, Xuanye Zhang, Yixin Zhou, et al.. (2021). Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus. Cancer Immunology Immunotherapy. 71(5). 1247–1255. 13 indexed citations
9.
10.
He, Lina, Xuanye Zhang, Haifeng Li, et al.. (2021). Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy. Frontiers in Oncology. 10. 621329–621329. 15 indexed citations
11.
Zhang, Xuanye, Dan Tian, Yue Chen, et al.. (2021). Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy. Translational Lung Cancer Research. 10(7). 3191–3202. 12 indexed citations
12.
13.
Chen, Chen, Xuanye Zhang, Yixin Zhou, et al.. (2020). <p>Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum</p>. Cancer Management and Research. Volume 12. 10353–10360. 2 indexed citations
14.
Chen, Chen, Yixin Zhou, Xuanye Zhang, et al.. (2020). Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma. Cancer Medicine. 9(5). 1721–1732. 13 indexed citations
15.
Lin, Zuan, Sha Fu, Yixin Zhou, et al.. (2019). First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma. Lung Cancer. 137. 100–107. 24 indexed citations
16.
Zhang, Xuanye, Yixin Zhou, Chen Chen, et al.. (2019). Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition. Journal for ImmunoTherapy of Cancer. 7(1). 322–322. 129 indexed citations
17.
Zhou, Yixin, Zuan Lin, Xuanye Zhang, et al.. (2019). First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 120–120. 56 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malin Sternby Eilard Breakdown of academic impact, for papers by Vincent E. Gaillard Breakdown of academic impact, for papers by Yugo Kai Breakdown of academic impact, for papers by Maridi Aerts Breakdown of academic impact, for papers by Yan‐Jun Xiang Breakdown of academic impact, for papers by Lorraine Blaise Breakdown of academic impact, for papers by Yizhen Fu Breakdown of academic impact, for papers by Guosheng Yuan Breakdown of academic impact, for papers by Morven Cunningham Breakdown of academic impact, for papers by Ann Tan
Rankless by CCL
2026